173 Search Results

q=Breast

Search Again


Eun Hyun Ahn , PhD

Email: ahneun@uw.edu

Dr. Ahn’s current research interests are focused on: Breast cancer stem cell mutagenesis and DNA repair and microenvironmental regulation of cancer stem cells and carcinogenesis. Dr.Ahn’s previous research areas include: (1) Identification and biochemical characterization of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma; (2) Regulation of differentiation of human mesenchymal stem cells and cardiac precursor cells by nanotopography-induced cellular stiffness and rigidity; (3) Roles of retinoic acids and retinoic acid receptorson proliferation, cell cycle, and cell signaling; (4) chemotherapeutic and chemopreventive mechanisms of sphingolipids in colon and breast cancers; Anti-tumorigenic activities of antisense oligonucleotides against AKT1 in various cancer cells.

View Bio

M. Robyn Andersen , PhD, MPH

Email: rander@fredhutch.org

Phone: (206) 667-6684

Dr. Andersen's research examines issues related to the adoption of medical technologies for the prevention and treatment of cancer. She is currently involved in projects examining psychosocial predictors of quality of life for breast and ovarian cancer survivors, the influence of Complimentary and Alternative (CAM) on cancer diagnosis and treatment and the potential of a symptoms index to improve early diagnosis of ovarian cancer.

View Bio

Benjamin Anderson , MD

Email: banderso@u.washington.edu

Phone: (206) 543-6352

Dr. Anderson is Professor of Surgery and Global Health Medicine at the University of Washington (UW) in Seattle where his practice is devoted to caring for patients with breast health issues and cancer. Dr. Anderson's clinical interests include oncoplastic breast surgery, which simultaneously improves oncologic and cosmetic outcomes with complex cancer resections. He holds joint faculty positions at the Fred Hutch Division of Public Health Sciences and the UW Department of Global Health. He directs the Breast Health Clinic at the Seattle Cancer Care Alliance (SCCA). From 2005-2007, Dr. Anderson served as President of the American Society of Breast Disease (ASBD). Dr. Anderson created and chairs the Breast Health Global Initiative (BHGI), which developed resource-stratified guidelines for breast cancer early detection, diagnosis and treatment in low- and middle-income countries (LMICs). On the U.S. delegation to the 58th World Health Assembly in Geneva, Dr. Anderson contributed to the 2005 World Health Organization (WHO) Cancer Prevention and Control Resolution. The American Society of Clinical Oncology (ASCO) awarded Dr. Anderson their 2011 Partners in Progress Award. In 2012, Dr. Anderson was elected to the Board of Directors of the Union for International Cancer Control (UICC), the oldest international professional organization addressing global cancer control. Dr. Anderson now chairs the National Comprehensive Cancer Network (NCCN) International Program Committee. Most recently, the National Consortium of Breast Centers (NCBC) awarded him their 2013 Inspiration Award, recognizing his dedication and efforts to improve quality and effectiveness of breast cancer care around the globe.

View Bio

Garnet Anderson , PhD

Email: garnet@whi.org

Phone: (206) 667-4699

Dr. Anderson's area of expertise are to design, analyze, and conduct randomized trials and Biostatistics. Her research interest is focused on Women's health; in particular in the area of prevention of chronic disease, health effects of menopausal hormone therapy, ovarian cancer, including biomarkers, screening, and risk.

View Bio

Justin Ashworth , PhD

Email: Justin.Ashworth@systemsbiology.org

Phone: (206) 732-2179

Dr. Ashworth is interested in the modeling and prediction of molecular and genetic variations in cellular systems, and the ways in which the functions and interactions of proteins are "designed" in nature to yield cellular physiologies and adaptations. Recently I have been studying gene regulation of new microorganisms and the functional roles of mutations in cellular systems in order to relate our biophysical understanding of molecular function and evolution to systems-level characteristics.

View Bio

Mike Averkiou , PhD

Email: maverk@uw.edu

Phone: (206) 616-9558

Dr. Averkiou develops new ultrasound imaging and therapy technology for disease detection, improved cancer treatment and monitoring, improved drug delivery to targeted cells, and heart disease. Using advanced nonlinear imaging techniques and microbubble contrast agents, he is able to detect the earliest stages of tumor angiogenesis and atherosclerosis, and closely monitor their treatment. He focuses on transferring innovations from preclinical research into clinical use.

View Bio

Geoffrey Baird , MD, PhD

Email: gbaird@uw.edu

Phone: (206)744-9787

Dr. Baird's clinical interests include laboratory test utilization, molecular diagnostics, proteomics and immunohistochemistry. His group has developed a new proteomic technology for biomarker discovery in a range of diseases such as malignancies, cardiovascular disorders, and inflammatory conditions. One application of their technology is to discover protein expression changes associated with non-small cell lung cancer that have implications for diagnosis and treatment.

View Bio

Laura Mae Baldwin , MD, MPH

Email: lmb@u.washington.edu

Phone: (206) 685-4799

Dr. Baldwin is a health services researcher with a focus on access to and quality of health care in diverse underserved and rural areas. Her areas of interest are cancer prevention and treatment, and perinatal health, all with an eye towards ensuring equitable access to high quality health services across U.S.

View Bio

William Barlow , PhD

Email: wbarlow@uw.edu

Phone: (206) 839-1761

Dr. Barlow's expertise is in the area of Biostatistics: it includes designing, conducting, and analyzing breast cancer clinical trials. His other interests include breast cancer screening, other clinical prognostic and predictive markers, trial design, and efficient sampling methods for biomarker evaluation.

View Bio

J David Beatty , MD

Email: David.beatty@swedish.org

Phone: (206) 320-4880

Dr. Beatty's practice and academic activities have been focused on breast cancer. His clinical practice emphasizes management of patients with complex breast care and breast cancer problems. His surgical expertise includes breast biopsy, minimally invasive technology, ultrasound guided procedures, sentinel node localization and biopsy, breast conserving surgery, oncoplastic surgery, axillary preserving surgery, image guided surgery, balloon catheter placement for partial breast irradiation, bloodless surgery, and integration of surgery and multidisciplinary care.

View Bio

William Bensinger , MD

Email: wbensing@fredhutch.org

Phone: (206) 667-4933

Dr. Bensinger treats patients with multiple myeloma, amyloidosis, and plasmacytoma. His clinical interests are Autologous Stem Cell Transplantation, Immunotherapy and Targeted Radiotherapy.

View Bio

Shirley Beresford , PhD, MSc, MA

Email: beresfrd@u.washington.edu

Phone: (206) 543-9512

Dr. Beresford's research interests are in the areas of nutritional epidemiology and chronic disease prevention; specifically designed to improve the scientific basis for public health policy and recommendations concerning dietary intake, physical activity and intake of folic acid.

View Bio

Slobodan Beronja , PhD

Email: beronja@fredhutch.org

Phone: (206) 667-7609

Dr. Beronja's group studies molecular and cellular mechanisms essential for tissue growth during development and the formation of tumors. His goal is to identifying genes and gene pathways that can be used as targets in cancer therapy.

View Bio

Parveen Bhatti , PhD

Email: pbhatti@fredhutch.org

Phone: (206) 667-7803

Dr. Bhatti's research focus is on occupational and environmental epidemiology of cancer with a focus in biomarkers of exposure, susceptibility and disease; particularly genetic susceptibility to cancer following low dose exposure to occupational or medical ionizing radiation.

View Bio

Jason Bielas , PhD

Email: jbielas@fredhutch.org

Dr. Bielas leads a group group studies the fundamental and clinical implications of nuclear and mitochondrial DNA mutations in the pathogenesis of cancer and age-related disease including breast and ovarian cancer. Recently, his laboratory has developed a new test for predicting ovarian cancer survival.

View Bio

C. Anthony (Tony) Blau , MD

Email: tblau@u.washington.edu

Phone: (206) 685-6873

Dr. Blau specializes in orchestrating collaborations across disparate scientific disciplines toward grand goals. As a physician-scientist he believes that our approach to cancer needs to be fundamentally restructured, and for this reason founded the UW's Center for Cancer Innovation (CCI). CCI applies the latest scientific knowledge to the treatment of today's cancer patients while using their experiences to benefit all cancer patients tomorrow. CCI recently launched its first clinical trial in an aggressive form of breast cancer called 'triple-negative' breast cancer. CCI is a grass-roots 'coalition of the willing,' comprised of nearly 100 community and academic oncologists, scientists, computational biologists, and other specialists from six different organizations, and owes much of its success to support from the South Sound region.

View Bio

Lynn Bonham , PhD

Email: lbonham@seattlecca.org

Phone: (206)288-2022

Dr. Bonham directs and manages Cellular Therapeutics at SCCA, which processes cells from peripheral blood, bone marrow and cord blood for standard transplantations and clinical trials for cancer treatment.

View Bio

Denise Boudreau , PhD, MS

Email: boudreau.d@ghc.org

Phone: (206) 287-2067

Dr. Boudreau's area of expertise is Pharmacoepidemiology. Her research ranges from cancer to cardiovascular disease. Her latest project explores the influence of commonly used medications such as statins and chronic antibiotic use on breast cancer outcomes. Dr. Boudreau is also an expert at pharmaco-economic studies such as reviewing the costs and effects of using medications on biologic and screening endpoints for breast cancer and cost of false positive mammography.

View Bio

Robert Bradley , PhD

Email: rbradley@fredhutch.org

Phone: (206) 667-5662

Dr. Bradley uses genomics, sequence analysis, and molecular genetics to study the mechanistic origins and phenotypic consequences of alternative splicing and other RNA processing. He wants to identify diseases where RNA processing plays important, and previously unrecognized, roles. His laboratory studies pre-neoplastic diseases and cancers such as brain, prostrate and breast cancer.

View Bio

Roger Brent , PhD

Email: rbrent@fredhutch.org

Phone: (206) 667-1482

Dr. Brent studies the quantitative operation of the systems that living cells use to sense, represent, transmit, and act upon information to make decisions that determine their future fates. He specifically studies prototypic cell signaling systems in budding yeast and the pheromone response system; he has extended similar work to systems operating in single cells of tissues in a metazoan, Caenorhabditis elegans.

View Bio